Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Switching the Smoothened Inhibitor May Have Benefit in Advanced Basal Cell Carcinoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Switching the Smoothened Inhibitor May Have Benefit in Advanced Basal Cell Carcinoma.
Switching the Smoothened Inhibitor May Have Benefit in Advanced Basal Cell Carcinoma. Am J Ther. 2018 May/Jun; 25(3):e394-e396.
View in:
PubMed
subject areas
Anilides
Anilides
Antineoplastic Agents
Antineoplastic Agents
Biphenyl Compounds
Biphenyl Compounds
Carcinoma, Basal Cell
Carcinoma, Basal Cell
Humans
Humans
Male
Male
Middle Aged
Middle Aged
Pyridines
Pyridines
Skin Neoplasms
Skin Neoplasms
Smoothened Receptor
Smoothened Receptor
Treatment Outcome
Treatment Outcome
authors with profiles
Sami Ibrahimi